$GSK Company News Mylan in second round bid fo
Post# of 89618
Posted On: 08/23/2014 12:21:25 PM
$GSK Company News
Mylan in second round bid for Glaxo portfolio: WSJ 2:39 p.m. Aug. 20, 2014 - MarketWatch.com
Glaxo chief faces increasing pressure: WSJ 6:29 p.m. Aug. 11, 2014 - MarketWatch.com
Super-Moon illusion or buy the dips on this stock market? 7:52 a.m. Aug. 11, 2014 - Barbara Kollmeyer
China’s anti-corruption drive: Is it reform in disguise? 1:26 a.m. Aug. 11, 2014 - Craig Stephen
Hungry for yield? Gobble up European stocks, says Goldman 10:43 a.m. Aug. 5, 2014 - Carla Mozee
FTSE 100 slumps for third day as miners, banks slump 12:12 p.m. Aug. 1, 2014 - Sara Sjolin
FTSE 100 erases gain after soft U.S. home sales data 12:07 p.m. July 28, 2014 - Sara Sjolin
Biogen rallies on earnings; Juniper slumps 10% 1:25 p.m. July 23, 2014 - Sue Chang
Glaxo slides in London after earnings warning 12:02 p.m. July 23, 2014 - Carla Mozee
GlaxoSmithKline lowers full-year profit outlook 7:48 a.m. July 23, 2014 - MarketWatch.com
U.K. growth data to reignite BOE rate chatter 5:08 a.m. July 22, 2014 - blogs.marketwatch.com
Emerging markets lift Novartis profit by 1.6% 1:39 a.m. July 17, 2014 - MarketWatch.com
Novartis lays out plan to overhaul business 3:14 a.m. June 18, 2014 - MarketWatch.com
GlaxoSmithKline reaches $105 million settlement with 44 states 3:19 p.m. June 4, 2014 - Russ Britt
Merck, Sanofi, Glaxo explore shedding older drugs 5:43 p.m. June 3, 2014 - MarketWatch.com
GlaxoSmithKline says U.K. fraud office is probing its commercial work 4:07 p.m. May 27, 2014 - Russ Britt
GlaxoSmithKline says U.K. fraud office probing firm 3:27 p.m. May 27, 2014 - Russ Britt
Vodafone pulls FTSE 100 from 14-year high 12:18 p.m. May 15, 2014 - Sara Sjolin
Glaxo's ex-China chief accused of bribery 1:20 a.m. May 14, 2014 - MarketWatch.com
Glaxo profit slides by almost a third 10:07 a.m. April 30, 2014 - MarketWatch.com
FDA approves single-pill regimen HIV med 3:32 p.m. Aug. 22, 2014 - Seeking Alpha
GlaxoSmithKline's (GSK) Arnuity Ellipta Approved by FDA - Analyst Blog 5:05 p.m. Aug. 21, 2014 - Zacks.com
3 Dividend Kings From The U.K. I Love To Buy 3:01 p.m. Aug. 21, 2014 - GuruFocus.com
Theravance Biopharma: Neglected Spinoff Targeting A Huge Underserved Market 9:32 a.m. Aug. 21, 2014 - Seeking Alpha
Novartis to Invest $35M in Gamida Cell for 15% Equity - Analyst Blog 6:13 p.m. Aug. 20, 2014 - Zacks.com
GSK expands fluticasone furoate label into asthma 3:49 p.m. Aug. 20, 2014 - Seeking Alpha
GlaxoSmithKline: The Bad Isn't All That Bad 3:39 p.m. Aug. 20, 2014 - Seeking Alpha
Why Mylan (MYL) Stock Is Advancing Today 3:01 p.m. Aug. 20, 2014 - TheStreet.com
UPDATE: GlaxoSmithKline Receives FDA Approval For Arnuity Ellipta In US For Treatment Of Asthma 2:36 p.m. Aug. 20, 2014 - benzinga.com
Hottest Healthcare Stocks Now – THOR GSK ESRX CNC 1:45 p.m. Aug. 20, 2014 - InvestorPlace.com
Eurozone Recovery Stalls in Q2: 3 Stocks to Sell Now - Analyst Blog 9:59 a.m. Aug. 20, 2014 - Zacks.com
Pernix acquires U.S. rights to Treximet 9:03 a.m. Aug. 20, 2014 - Seeking Alpha
Yes, Call it a Comeback: Amicus Fabry Drug Posts Big Study Win 6:01 a.m. Aug. 20, 2014 - TheStreet.com
GlaxoSmithKline: To Buy Or Not To Buy? 12:27 p.m. Aug. 19, 2014 - Seeking Alpha
Kindred 30.33% Upside Paced Healthcare August Dividend Dogs 9:18 p.m. Aug. 18, 2014 - Seeking Alpha
Sinopharm, Biostar, Lilly Rise on Medical Modernization in China 2:11 p.m. Aug. 18, 2014 - TheStreet.com
Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, MFG 10:54 a.m. Aug. 18, 2014 - GuruFocus.com
Why GlaxoSmithKline Is A Tempting Buy 5:10 p.m. Aug. 14, 2014 - Seeking Alpha
Major Portfolio Changes for Warren Buffett and Berkshire Hathaway 4:40 p.m. Aug. 14, 2014 - 247WallSt.com
Ebola vaccine trials are a top priority for medical authorities 1:20 p.m. Aug. 14, 2014 - Seeking Alpha
ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection 3:46 p.m. Aug. 22, 2014 - PR Newswire - PRF
Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 11:00 a.m. Aug. 21, 2014 - PR Newswire - PRF
Pharma Stocks Review -- Eli Lilly, Zogenix, GlaxoSmithKline, Novo Nordisk, and Valeant Pharma Intl. 9:20 a.m. Aug. 21, 2014 - PR Newswire - PRF
GSK receives FDA approval for Arnuity™ Ellipta® (fluticasone furoate) in the US for the treatment of asthma 3:33 p.m. Aug. 20, 2014 - PR Newswire - PRF
Pernix Therapeutics Closes Acquisition of Treximet. Raises $220m Senior Notes. Issues Updated 2014 Guidance. 8:02 a.m. Aug. 20, 2014 - BusinessWire - BZX
POZEN Announces U.S. Rights For TREXIMET® Have Been Acquired by Pernix Therapeutics 8:00 a.m. Aug. 20, 2014 - BusinessWire - BZX
North American Pharma-Biotech Sector to Wrap Up Construction on 157 Projects Worth $1.3 Billion in Third-Quarter 2014, an Industrial Info News Alert 6:15 a.m. Aug. 20, 2014 - Marketwire
Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 1:19 p.m. Aug. 19, 2014 - PR Newswire - PRF
Sanford-Burnham Appoints Perry Nisen as Chief Executive Officer 1:00 p.m. Aug. 19, 2014 - Marketwire
Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna 8:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Inotek Pharmaceuticals Names David P. Southwell as President and Chief Executive Officer 9:01 a.m. Aug. 13, 2014 - BusinessWire - BZX
Potential Payoffs Spur Big Board Biotech Action 3:03 p.m. Aug. 12, 2014 - ACCESSWIRE
Thrasos Appoints Gaétan Gravel andJoseph Zakrzewski to Board of Directors 9:01 a.m. Aug. 12, 2014 - BusinessWire - BZX
Spasticity Global Clinical Trials Review, H2, 2014 4:42 p.m. Aug. 11, 2014 - PR Newswire - PRF
Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014 4:39 p.m. Aug. 11, 2014 - PR Newswire - PRF
Sears Holdings Names Alasdair James As Kmart's President And Chief Member Officer 2:47 p.m. Aug. 11, 2014 - PR Newswire - PRF
Sponsor And CRO Finalists Announced For Annual Society For Clinical Research Sites Eagle Award 12:08 p.m. Aug. 11, 2014 - PR Newswire - PRF
Dynavax Reports Second Quarter 2014 Financial Results and Safety and Pharmacodynamic Results for Asthma and Lupus Drug Candidates 6:01 a.m. Aug. 7, 2014 - Marketwire
New Joint Ventures, Course Launches, Study Results, Earnings Performance, and Approvals - Research Reports on Johnson Controls, Intuitive Surgical, GlaxoSmithKline, Community Health and Vertex 8:50 a.m. Aug. 6, 2014 - PR Newswire - PRF
GSK's COPD.com Relaunch Promotes Understanding and Dialogue about COPD 9:00 a.m. Aug. 5, 2014 - PR Newswire - PRF
Mylan in second round bid for Glaxo portfolio: WSJ 2:39 p.m. Aug. 20, 2014 - MarketWatch.com
Glaxo chief faces increasing pressure: WSJ 6:29 p.m. Aug. 11, 2014 - MarketWatch.com
Super-Moon illusion or buy the dips on this stock market? 7:52 a.m. Aug. 11, 2014 - Barbara Kollmeyer
China’s anti-corruption drive: Is it reform in disguise? 1:26 a.m. Aug. 11, 2014 - Craig Stephen
Hungry for yield? Gobble up European stocks, says Goldman 10:43 a.m. Aug. 5, 2014 - Carla Mozee
FTSE 100 slumps for third day as miners, banks slump 12:12 p.m. Aug. 1, 2014 - Sara Sjolin
FTSE 100 erases gain after soft U.S. home sales data 12:07 p.m. July 28, 2014 - Sara Sjolin
Biogen rallies on earnings; Juniper slumps 10% 1:25 p.m. July 23, 2014 - Sue Chang
Glaxo slides in London after earnings warning 12:02 p.m. July 23, 2014 - Carla Mozee
GlaxoSmithKline lowers full-year profit outlook 7:48 a.m. July 23, 2014 - MarketWatch.com
U.K. growth data to reignite BOE rate chatter 5:08 a.m. July 22, 2014 - blogs.marketwatch.com
Emerging markets lift Novartis profit by 1.6% 1:39 a.m. July 17, 2014 - MarketWatch.com
Novartis lays out plan to overhaul business 3:14 a.m. June 18, 2014 - MarketWatch.com
GlaxoSmithKline reaches $105 million settlement with 44 states 3:19 p.m. June 4, 2014 - Russ Britt
Merck, Sanofi, Glaxo explore shedding older drugs 5:43 p.m. June 3, 2014 - MarketWatch.com
GlaxoSmithKline says U.K. fraud office is probing its commercial work 4:07 p.m. May 27, 2014 - Russ Britt
GlaxoSmithKline says U.K. fraud office probing firm 3:27 p.m. May 27, 2014 - Russ Britt
Vodafone pulls FTSE 100 from 14-year high 12:18 p.m. May 15, 2014 - Sara Sjolin
Glaxo's ex-China chief accused of bribery 1:20 a.m. May 14, 2014 - MarketWatch.com
Glaxo profit slides by almost a third 10:07 a.m. April 30, 2014 - MarketWatch.com
FDA approves single-pill regimen HIV med 3:32 p.m. Aug. 22, 2014 - Seeking Alpha
GlaxoSmithKline's (GSK) Arnuity Ellipta Approved by FDA - Analyst Blog 5:05 p.m. Aug. 21, 2014 - Zacks.com
3 Dividend Kings From The U.K. I Love To Buy 3:01 p.m. Aug. 21, 2014 - GuruFocus.com
Theravance Biopharma: Neglected Spinoff Targeting A Huge Underserved Market 9:32 a.m. Aug. 21, 2014 - Seeking Alpha
Novartis to Invest $35M in Gamida Cell for 15% Equity - Analyst Blog 6:13 p.m. Aug. 20, 2014 - Zacks.com
GSK expands fluticasone furoate label into asthma 3:49 p.m. Aug. 20, 2014 - Seeking Alpha
GlaxoSmithKline: The Bad Isn't All That Bad 3:39 p.m. Aug. 20, 2014 - Seeking Alpha
Why Mylan (MYL) Stock Is Advancing Today 3:01 p.m. Aug. 20, 2014 - TheStreet.com
UPDATE: GlaxoSmithKline Receives FDA Approval For Arnuity Ellipta In US For Treatment Of Asthma 2:36 p.m. Aug. 20, 2014 - benzinga.com
Hottest Healthcare Stocks Now – THOR GSK ESRX CNC 1:45 p.m. Aug. 20, 2014 - InvestorPlace.com
Eurozone Recovery Stalls in Q2: 3 Stocks to Sell Now - Analyst Blog 9:59 a.m. Aug. 20, 2014 - Zacks.com
Pernix acquires U.S. rights to Treximet 9:03 a.m. Aug. 20, 2014 - Seeking Alpha
Yes, Call it a Comeback: Amicus Fabry Drug Posts Big Study Win 6:01 a.m. Aug. 20, 2014 - TheStreet.com
GlaxoSmithKline: To Buy Or Not To Buy? 12:27 p.m. Aug. 19, 2014 - Seeking Alpha
Kindred 30.33% Upside Paced Healthcare August Dividend Dogs 9:18 p.m. Aug. 18, 2014 - Seeking Alpha
Sinopharm, Biostar, Lilly Rise on Medical Modernization in China 2:11 p.m. Aug. 18, 2014 - TheStreet.com
Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, MFG 10:54 a.m. Aug. 18, 2014 - GuruFocus.com
Why GlaxoSmithKline Is A Tempting Buy 5:10 p.m. Aug. 14, 2014 - Seeking Alpha
Major Portfolio Changes for Warren Buffett and Berkshire Hathaway 4:40 p.m. Aug. 14, 2014 - 247WallSt.com
Ebola vaccine trials are a top priority for medical authorities 1:20 p.m. Aug. 14, 2014 - Seeking Alpha
ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection 3:46 p.m. Aug. 22, 2014 - PR Newswire - PRF
Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 11:00 a.m. Aug. 21, 2014 - PR Newswire - PRF
Pharma Stocks Review -- Eli Lilly, Zogenix, GlaxoSmithKline, Novo Nordisk, and Valeant Pharma Intl. 9:20 a.m. Aug. 21, 2014 - PR Newswire - PRF
GSK receives FDA approval for Arnuity™ Ellipta® (fluticasone furoate) in the US for the treatment of asthma 3:33 p.m. Aug. 20, 2014 - PR Newswire - PRF
Pernix Therapeutics Closes Acquisition of Treximet. Raises $220m Senior Notes. Issues Updated 2014 Guidance. 8:02 a.m. Aug. 20, 2014 - BusinessWire - BZX
POZEN Announces U.S. Rights For TREXIMET® Have Been Acquired by Pernix Therapeutics 8:00 a.m. Aug. 20, 2014 - BusinessWire - BZX
North American Pharma-Biotech Sector to Wrap Up Construction on 157 Projects Worth $1.3 Billion in Third-Quarter 2014, an Industrial Info News Alert 6:15 a.m. Aug. 20, 2014 - Marketwire
Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 1:19 p.m. Aug. 19, 2014 - PR Newswire - PRF
Sanford-Burnham Appoints Perry Nisen as Chief Executive Officer 1:00 p.m. Aug. 19, 2014 - Marketwire
Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna 8:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Inotek Pharmaceuticals Names David P. Southwell as President and Chief Executive Officer 9:01 a.m. Aug. 13, 2014 - BusinessWire - BZX
Potential Payoffs Spur Big Board Biotech Action 3:03 p.m. Aug. 12, 2014 - ACCESSWIRE
Thrasos Appoints Gaétan Gravel andJoseph Zakrzewski to Board of Directors 9:01 a.m. Aug. 12, 2014 - BusinessWire - BZX
Spasticity Global Clinical Trials Review, H2, 2014 4:42 p.m. Aug. 11, 2014 - PR Newswire - PRF
Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014 4:39 p.m. Aug. 11, 2014 - PR Newswire - PRF
Sears Holdings Names Alasdair James As Kmart's President And Chief Member Officer 2:47 p.m. Aug. 11, 2014 - PR Newswire - PRF
Sponsor And CRO Finalists Announced For Annual Society For Clinical Research Sites Eagle Award 12:08 p.m. Aug. 11, 2014 - PR Newswire - PRF
Dynavax Reports Second Quarter 2014 Financial Results and Safety and Pharmacodynamic Results for Asthma and Lupus Drug Candidates 6:01 a.m. Aug. 7, 2014 - Marketwire
New Joint Ventures, Course Launches, Study Results, Earnings Performance, and Approvals - Research Reports on Johnson Controls, Intuitive Surgical, GlaxoSmithKline, Community Health and Vertex 8:50 a.m. Aug. 6, 2014 - PR Newswire - PRF
GSK's COPD.com Relaunch Promotes Understanding and Dialogue about COPD 9:00 a.m. Aug. 5, 2014 - PR Newswire - PRF
(0)
(0)